AllianceBernstein’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $158K | Buy |
+10,570
| New | +$158K | ﹤0.01% | 3102 |
|
|
2024
Q4 | – | Sell |
-65,119
| Closed | -$2.73M | – | 3241 |
|
|
2024
Q3 | $2.73M | Buy |
+65,119
| New | +$2.73M | ﹤0.01% | 1810 |
|
|
2022
Q2 | – | Sell |
-1,125
| Closed | -$42K | – | 3328 |
|
|
2022
Q1 | $42K | Sell |
1,125
-130
| -10% | -$4.85K | ﹤0.01% | 3174 |
|
|
2021
Q4 | $121K | Sell |
1,255
-65
| -5% | -$6.27K | ﹤0.01% | 3161 |
|
|
2021
Q3 | $191K | Hold |
1,320
| – | – | ﹤0.01% | 3090 |
|
|
2021
Q2 | $244K | Buy |
1,320
+210
| +19% | +$38.8K | ﹤0.01% | 3080 |
|
|
2021
Q1 | $273K | Sell |
1,110
-115
| -9% | -$28.3K | ﹤0.01% | 2928 |
|
|
2020
Q4 | $345K | Hold |
1,225
| – | – | ﹤0.01% | 2780 |
|
|
2020
Q3 | $294K | Buy |
1,225
+280
| +30% | +$67.2K | ﹤0.01% | 2814 |
|
|
2020
Q2 | $314K | Buy |
+945
| New | +$314K | ﹤0.01% | 2845 |
|